May 15, 2024- MediGroup will now offer CerroZone’s state-of-the-art air purification devices to its more than 25,000 members. The patented, FDA-approved CerroZone system safely harnesses powerful oxidation technology to kill 99.99% of viruses, bacteria, mold and other airborne pathogens. It also eliminates odors and volatile organic compounds (VOCs), such as ammonia and formaldehyde.
CerroZone’s unique, patented technology uses internal UV-C lamps to generate ozone within a sealed mixing chamber. Air is drawn into the unit and exposed to the ozone, which deactivates pathogens, including viruses, bacteria, mold, fungus and VOCs. The mixed air then passes through a proprietary catalyst that restructures the air chemistry, converting all ozone (O3) into oxygen (O2), before returning fresh, sanitized air to the room.
In independent laboratory testing, CerroZone recorded a 99.99%+ reduction of COVID-19 (SARS-CoV-2) virus in a single pass, in just 1.2 seconds. Similar results were achieved with other viruses, such as RNA and MS2, as well as mold and VOCs.
The CerroZone mobile unit is certified by the FDA as a 510(k) Class II medical device and complies with the American Society of Heating, Refrigerating and Air-Conditioning Engineers (ASHRAE) Standard 241. CerroZone also complies with UL 2998 and has Intertek’s Zero Ozone Certification, meaning ozone levels in air leaving the unit are below the quantifiable limit of detection of 0.005 ppm.